NTPC Ltd‘s renewable energy arm is considering terminating two contracts close to 500 MW awarded to troubled Gensol Engineering Ltd for engineering, procurement, and construction (EPC) work. It may also cancel a third project that was in the process of being awarded to the solar EPC company, people aware of the development said. “An insignificant… Continue reading NTPC may cancel two contracts of 500 MW awarded to Gensol Engineering
Tag: People
Trump to tout US investments from Nvidia, J&J, Hyundai, Toyota
Trump has said he is considering granting automakers some relief from new auto tariffs. CEOs and senior executives from Nvidia, Johnson & Johnson, Hyundai Motor, Toyota Motor, and SoftBank Group are among the more than two-dozen business leaders slated to visit the White House on Wednesday for an event highlighting U.S. investments, officials told Reuters.… Continue reading Trump to tout US investments from Nvidia, J&J, Hyundai, Toyota
VidAU AI Secured New Round of Funding to Redefine Video Ad Creation
LOS ANGELES, April 29, 2025 /PRNewswire/ — VidAU AI, a trailblazer in AI-powered video advertising, has secured a new round of funding round led by Nuohai Venture Capital. Building on its Pre-A round in September 2024 with Nuohui Investment and earlier support from River Jin Technology, this investment marks a pivotal milestone for the company. With… Continue reading VidAU AI Secured New Round of Funding to Redefine Video Ad Creation
Sobi publishes Q1 2025 report: Portfolio continues to deliver
STOCKHOLM, April 29, 2025 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2025 First Quarter 2025 Total revenue increased 3 per cent, 3 per cent at constant exchange rates, (CER)1, to SEK 6,465 M (6,256) Haematology revenue increased 13 per cent at CER to SEK 4,632 M (4,075),… Continue reading Sobi publishes Q1 2025 report: Portfolio continues to deliver
Sobi publishes Q1 2025 report: Portfolio continues to deliver
STOCKHOLM, April 29, 2025 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2025 First Quarter 2025 Total revenue increased 3 per cent, 3 per cent at constant exchange rates, (CER)1, to SEK 6,465 M (6,256) Haematology revenue increased 13 per cent at CER to SEK 4,632 M (4,075),… Continue reading Sobi publishes Q1 2025 report: Portfolio continues to deliver
Nucleus Synapse 2025 Ignites the Human-AI Alliance as the Middle East Leads the Charge in AI-Powered Banking
DUBAI, UAE, April 29, 2025 /PRNewswire/ — The Middle East isn’t just adopting digital transformation—it’s engineering the future of banking with bold leadership, smart regulation, and rapid AI investment. It is in this spirit of transformation that Nucleus Software convened Synapse 2025 – Middle East, held at the iconic Taj Exotic Resorts, The Palm, Dubai, uniting… Continue reading Nucleus Synapse 2025 Ignites the Human-AI Alliance as the Middle East Leads the Charge in AI-Powered Banking
Michigan Expands Statewide Initiative to Support Adults Returning to College, Increase Number of Accessible Pathways to Credential Attainment
In partnership with ReUp Education, Michigan has expanded its Michigan Reconnect initiative in support of the state’s 1.2 million some college no credential residents with robust college coaching and support. LANSING, Mich., April 29, 2025 /PRNewswire/ — ReUp Education, a national leader in college re-enrollment and workforce readiness, has announced an expanded partnership with the… Continue reading Michigan Expands Statewide Initiative to Support Adults Returning to College, Increase Number of Accessible Pathways to Credential Attainment
CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy
European Commission converts conditional approval of FILSPARI (sparsentan) into standard marketing authorization for the treatment of IgA Nephropathy (IgAN) Decision follows positive recommendation from Committee for Medicinal Products for Human Use (CHMP) from February 2025 EU approval is based on the complete data set from the phase-III PROTECT study ST. GALLEN, Switzerland and SAN DIEGO, April… Continue reading CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy
HR Path Expands Presence with the Acquisition of smahrt consulting AG in Switzerland, Experts in HR-IT Consulting, Implementation and Outsourcing
PARIS, April 29, 2025 /PRNewswire/ — HR Path, a global leader in HR consulting and HRIS solutions, is proud to announce its strategic acquisition of smahrt consulting AG, a Swiss-based company specializing in HR-IT consulting, implementation and outsourcing. Especially within the SAP product portfolio. Continue Reading HR Path Expands Presence with the Acquisition of smahrt consulting… Continue reading HR Path Expands Presence with the Acquisition of smahrt consulting AG in Switzerland, Experts in HR-IT Consulting, Implementation and Outsourcing
CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy
European Commission converts conditional approval of FILSPARI (sparsentan) into standard marketing authorization for the treatment of IgA Nephropathy (IgAN) Decision follows positive recommendation from Committee for Medicinal Products for Human Use (CHMP) from February 2025 EU approval is based on the complete data set from the phase-III PROTECT study ST. GALLEN, Switzerland and SAN DIEGO, April… Continue reading CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy